# UQUIFA Mexico, S.A. de C.V. - Inspection Records

Source: https://www.keypedia.com/companies/uquifa-mexico-sa-de-cv/8523a240-e52a-495e-a781-e12c6412dc69

> Inspection records and compliance data for UQUIFA Mexico, S.A. de C.V. in Jiutepec, None. Access full analysis and detailed observations.

---

## Details

- Name: UQUIFA Mexico, S.A. de C.V.
- FEI Number: 1000260514
- City: Jiutepec
- State: None
- Country Name: Mexico
- Address Line 1: Calle 37 Este No 126 Apdo 430, Jiutepec
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - UQUIFA Mexico, S.A. de C.V. - 2018-07-27](https://www.keypedia.com/records/483/uquifa-mexico-sa-de-cv/b54d47c7-3e1c-4d8a-aa98-e6582f014a93) — source: FDA, date: July 27, 2018
- [FDA Inspection 1062926 - UQUIFA Mexico, S.A. de C.V. - 2018-07-27](https://www.keypedia.com/records/fda_inspections/uquifa-mexico-sa-de-cv/bb53c134-bb8e-4ef9-8c83-c573255d2626) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 27, 2018
- [483 - UQUIFA Mexico, S.A. de C.V. - 2018-07-23](https://www.keypedia.com/records/483/uquifa-mexico-sa-de-cv/6590baa9-efdb-4584-bd03-0eeca55aa6fa) — source: FDA, date: July 23, 2018
- [FDA Inspection 895641 - UQUIFA Mexico, S.A. de C.V. - 2014-09-12](https://www.keypedia.com/records/fda_inspections/uquifa-mexico-sa-de-cv/87861ab9-96a2-403a-991b-af5f3abe0626) — classification: No Action Indicated (NAI), source: FDA, date: September 12, 2014
- [FDA Inspection 742884 - UQUIFA Mexico, S.A. de C.V. - 2011-08-04](https://www.keypedia.com/records/fda_inspections/uquifa-mexico-sa-de-cv/0b19a353-f0b1-4cbc-a6df-fbdc9a50e399) — classification: No Action Indicated (NAI), source: FDA, date: August 4, 2011

## Related Companies

- [Lonza Biologics, Inc.](https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff)
- [Biogen MA Inc.](https://www.keypedia.com/companies/biogen-ma-inc/85b778d2-1e69-485d-9e93-05c656646fa2)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/f0157d2d-6b0c-4b13-afd4-551c2ab94aad)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264)
- [Spark Therapeutics, Inc.](https://www.keypedia.com/companies/spark-therapeutics-inc/a5518493-a117-41d3-862d-96d5a5d3b6dd)
- [Organo Sintesis, S.A. De C.V.](https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d)
- [MSN Laboratories Private Limited, Unit-II](https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a)
- [AGILENT TECHNOLOGIES INC./US](https://www.keypedia.com/companies/agilent-technologies-incus/f39880d4-233e-44bc-9a9e-56d1f9b48065)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michael-a-charles/f83241f0-ae3b-4535-ac03-e790bbf666ca)